Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04822597 · ClinicalTrials.gov registry record · Phase 3
Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer
A Phase 3 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 3
- Development phase
- 167
- Enrollment target
NCT04822597 is a Phase 3 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 167 participants.
The verdict
NCT04822597, a Phase 3 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness four different pain treatments for the injection of radioactive tracer that women with breast cancer receive for sentinel lymph node biopsies. This study will include women who have been diagnosed with breast cancer and who will be undergoing sentinel lymph node biopsy with a standard injection of radioactive tracer before surgery. A participant's active participation will take place on two separate occasions. In the first occasion, a participant will complete a brief pain assessment on the day of enrollment. The rest of a participant's active participation will take place on one day (the day of surgery) and last approximately 20 minutes, after which active participation will end.
Interventions
- DRUG Lidocaine patch
- OTHER Ice pack
- DEVICE Buzzy(R)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2022-05-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04822597
The ClinicalTrials.gov registry entry for NCT04822597 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lidocaine patch is the first listed.
NCT04822597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04822597 about?
NCT04822597 is a clinical study titled "Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer". The purpose of this study is to compare the effectiveness four different pain treatments for the injection of radioactive tracer that women with breast cancer receive for sentinel lymph node biopsies. This study will include women who have been diagnosed with breast cancer and who will be undergoin...
What is the current status of trial NCT04822597?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 167 participants. The study started on 2021-04-23. Estimated completion is 2022-05-09.
What interventions are being tested in trial NCT04822597?
The interventions under investigation include: Lidocaine patch (DRUG), Ice pack (OTHER), Buzzy(R) (DEVICE).
Who is sponsoring clinical trial NCT04822597?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.